Average Co-Inventor Count = 4.56
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cell Pathways (17 from 75 patents)
2. University of Arizona (6 from 972 patents)
3. Other (1 from 832,680 patents)
19 patents:
1. 6610854 - Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia
2. 6486158 - [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
3. 6426349 - Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
4. 6403831 - Substituted benzylidene indenyl formamides, acetamides and propionamides
5. 6300346 - Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
6. 6180629 - [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
7. 6166053 - Substituted condensation products of N-benzyl-3-idenylacetamides with
8. 6121321 - Substituted methoxy benzylidene indenyl acetic and propionic acids for
9. 6071934 - Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating
10. 6066634 - Substituted condensation products of N-benzyl-3-indenylacetamides
11. 6063818 - Substituted benzylidene indenyl formamides, acetamides and propionamides
12. 6028116 - Substituted condensation products of 1H-indenyl-hydroxyalkanes with
13. 5998477 - Substituted methoxy benzylidene indenyl-acetic and propionic acids for
14. 5965619 - Method for treating patients having precancerous lesions with
15. 5948779 - Substituted condensation products of n-benzyl-3-indenyl acetamides with